Company intelligence / Profile preview
Soley Therapeutics
South San Francisco, California, United Statessoleytherapeutics.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Soley Therapeutics has developed a proprietary high-throughput platform leveraging cellular responses and artificial intelligence/machine learning to predict cell fate. The company is focused on revolutionizing early-stage drug discovery but has not publicly disclosed clinical results or advanced clinical programs yet
- Therapeutic areas
- OncologyNeurology
- Modalities
- small molecules
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
Oracle Cloud Infrastructure for advancing AI-driven drug discovery capabilities
Beyond the preview
Go deeper on Soley Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Soley Therapeutics.